Save information for later
Sign Up

Learn About Epidermolysis Bullosa Acquisita

What is the definition of Epidermolysis Bullosa Acquisita?
Epidermolysis bullosa acquisita (EBA) is a rare autoimmune disorder that causes the skin to blister in response to minor injury. Common areas of blistering include the hands, feet, knees, elbows, and buttocks. It can also affect the mouth, nose, and eyes. Some affected people have other health problems such as Crohn's disease, systemic lupus erythematosus, amyloidosis, or multiple myeloma. EBA is not inherited and usually occurs in adulthood. Immunosuppressive drugs may be used to reduce the body's autoimmune response.
What are the alternative names for Epidermolysis Bullosa Acquisita?
  • Epidermolysis bullosa acquisita
  • Acquired epidermolysis bullosa
  • EB acquisita
  • EBA
Who are the top Epidermolysis Bullosa Acquisita Local Doctors?
Elite in Epidermolysis Bullosa Acquisita
Elite in Epidermolysis Bullosa Acquisita
Ratzeburger Allee 160, 
Luebeck, SH, DE 

Katja Bieber practices in Luebeck, Germany. Ms. Bieber is rated as an Elite expert by MediFind in the treatment of Epidermolysis Bullosa Acquisita. Her top areas of expertise are Epidermolysis Bullosa Acquisita, Bullous Pemphigoid, Epidermolysis Bullosa, and Bullae.

Elite in Epidermolysis Bullosa Acquisita
Elite in Epidermolysis Bullosa Acquisita
Ratzeburger Allee 160, 
Luebeck, SH, DE 

Detlef Zillikens practices in Luebeck, Germany. Zillikens is rated as an Elite expert by MediFind in the treatment of Epidermolysis Bullosa Acquisita. Their top areas of expertise are Epidermolysis Bullosa Acquisita, Bullous Pemphigoid, Epidermolysis Bullosa, and Bullae.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Epidermolysis Bullosa Acquisita
Elite in Epidermolysis Bullosa Acquisita
Ratzeburger Allee 160, 
Luebeck, SH, DE 

Ralf Ludwig practices in Luebeck, Germany. Mr. Ludwig is rated as an Elite expert by MediFind in the treatment of Epidermolysis Bullosa Acquisita. His top areas of expertise are Epidermolysis Bullosa Acquisita, Epidermolysis Bullosa, Bullous Pemphigoid, and Bullae.

What are the latest Epidermolysis Bullosa Acquisita Clinical Trials?
Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Summary: The study objective is to see if IV IgG treatment in Recessive Dystrophic Epidermolysis Bullosa (RDEB) skin in conjunction with VYJUVEK treatment improves wound healing and affects the levels of C7 and HSV-1 antibody levels in serum. Fewer wounds, more rapidly healing wounds, and decreased C7 and HSV-1 antibodies could improve quality of life.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center